FDA Approved: DEFERASIROX ORAL — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved a supplemental application for Deferasirox oral from Ascend Laboratories, LLC, advancing regulatory approval of this iron chelator product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload

Drugs mentioned

• Deferasirox oral (Deferasirox)

Snippet

SUPPL AP for DEFERASIROX ORAL (DEFERASIROX ORAL)